Conclusions: The results suggest that ECP is a feasible treatment for patients with glomerulopathies associated with nephrotic syndrome who have adequate baseline renal function. Additional clinical evaluation will have to be performed to better define the patient population in which ECP is most effective.
PMID: 20091491 [PubMed - in process] (Source: Journal of Nephrology)